Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN43859589
ISRCTN43859589
Completed
Phase 2

Phase II trial for neoadjuvant chemotherapy in patients with locally advanced and /or nodal positive gastric cancer (UICC stages IIIa, IIIb and IV M0) with Docetaxel, Cisplatin and 5-F

Medical University of Greifswald (Germany)0 sites46 target enrollmentOctober 18, 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsocally advanced and/or nodal positive gastric cancer (UICC Stages: IIIa, IIIb, IV M0)CancerMalignant neoplasm of stomach

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
ocally advanced and/or nodal positive gastric cancer (UICC Stages: IIIa, IIIb, IV M0)
Sponsor
Medical University of Greifswald (Germany)
Enrollment
46
Status
Completed
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 18, 2011
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Medical University of Greifswald (Germany)

Eligibility Criteria

Inclusion Criteria

  • •1\. Locally advanced and/or node positive gastric adenocarcinoma (UICC stages IIIa, IIIb, IV and M0\)
  • •2\. Aged 18 years and older
  • •3\. Eastern Cooperative Oncology Group Performance Status (ECOG PS): 0 \- 2
  • •4\. Adequate organ function
  • •5\. Signed informed consent
  • •6\. Participants: patients of both genders, no healthy volunteers

Exclusion Criteria

  • •1\. Metastatic disease
  • •2\. Prior chemotherapy for gastric cancer
  • •3\. Tumour recurrence after gastrectomy
  • •4\. Estimated life expectancy \< 3 months
  • •5\. Presence of any serious concomitant systemic disorder

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
A Phase 2 tRial of nEoadjuvant Chemotherapy in patiEnts with raDically reEectable upper tract urothelial carcinoma (PRECEDE trial)A randomized Phase 2 tRial of nEoadjuvant Chemotherapy vErsus aDjuvant chEmotherapy in patients with radically resectable upper tract urothelial carcinoma (PRECEDE trial)Neoplasms
KCT0008059Asan Medical Center30
Completed
Phase 1
Phase I/II trial of neoadjuvant chemotherapy with cisplatin and weekly paclitaxel in patients with stage Ib2- IIb uterine cervical cancerpatients with clinical stage Ib2, IIa(primary tumor diameter4 or more cm),IIb uterine cervical cancer
JPRN-UMIN000002636Hyogo Cancer Center40
Recruiting
Phase 1
Phase I/II trial of neoadjuvant chemotherapy with UFT/Leucovorin and Irinotecan plus radiation in patients with locally advanced rectal cancer.ocally advanced rectal cancer with preoperative diagnosis of T3-4 and N0-3.
JPRN-UMIN000006208The University of Tokyo Hospital. Department of surgical oncology.39
Recruiting
Phase 2
A phase II trial of neoadjuvant chemotherapy using the combination of gemcitabine and cisplatin for patients with initially unresectable locally advanced biliary tract cancer.Biliary tract cancer (Intrahepatic cholangiocarcinoma, Extrahepatic cholangiocarcinoma, Gallbladder carcinoma)
JPRN-UMIN000015330Adjuvant therapy for BTC Research Group50
Recruiting
Not Applicable
A phase II trial of neoadjuvant chemotherapy with docetaxel,cisplatin and S-1 (DCS) for radically resectable advanced gastric carcinoma (KDOG 1001)radically resectable advanced gastric carcinoma
JPRN-UMIN000003642Kitasato University School of Medicine40